Literature DB >> 2707393

HTLV-1 seroprevalence in AIDS patients and in HIV-1 seropositive and seronegative subjects at risk for AIDS in northern Italy.

N Manca1, A Caruso, C Bonfanti, E Savoldi, R Li Vigni, F Pirali, P L Sapelli, A Turano.   

Abstract

Sera of 1023 subjects belonging to categories at risk for AIDS, positive for HIV-1, were tested for antibodies to human T-cell leukemia virus (HTLV-1) by ELISA, Western blotting, and radioimmunoprecipitation (RIP) assay. Sera of these subjects were positive for antibodies to HTLV-1 in a percentage of 18.54%. Nine out of 18 sera from patients with AIDS had antibodies to HTLV-1 (50%). Sera of 207 intravenous drug abusers and 64 homosexual males, seronegative for HIV-1, were tested for antibodies to HTLV-1 and 6.7% of intravenous drug abusers and 7.8% of homosexual males were found to be HTLV-1 antibody positive, showing that HTLV-1 infection occurred independently of HIV-1 and HIV-2 infections. In fact the same HIV-1 seronegative patients were also tested for the presence of antibodies to HIV-2 and none of them was found to be positive.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2707393     DOI: 10.1007/BF00145042

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  20 in total

1.  Differential response to the cytopathic effects of human T-cell lymphotropic virus type III (HTLV-III) superinfection in T4+ (helper) and T8+ (suppressor) T-cell clones transformed by HTLV-I.

Authors:  A De Rossi; G Franchini; A Aldovini; A Del Mistro; L Chieco-Bianchi; R C Gallo; F Wong-Staal
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

3.  HIV-1 production from infected peripheral blood T cells after HTLV-I induced mitogenic stimulation.

Authors:  J A Zack; A J Cann; J P Lugo; I S Chen
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

4.  Sex as a risk factor for HTLV-I spread among intravenous drug abusers.

Authors:  G Rezza; F Titti; G B Rossi; P Verani; F Menniti-Ippolito; C Oliva
Journal:  Lancet       Date:  1988-03-26       Impact factor: 79.321

5.  Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nation-wide sero-epidemiologic study.

Authors:  Y Hinuma; H Komoda; T Chosa; T Kondo; M Kohakura; T Takenaka; M Kikuchi; M Ichimaru; K Yunoki; I Sato; R Matsuo; Y Takiuchi; H Uchino; M Hanaoka
Journal:  Int J Cancer       Date:  1982-06-15       Impact factor: 7.396

6.  Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region.

Authors:  M Robert-Guroff; S H Weiss; J A Giron; A M Jennings; H M Ginzburg; I B Margolis; W A Blattner; R C Gallo
Journal:  JAMA       Date:  1986-06-13       Impact factor: 56.272

7.  Adult T-cell lymphoma-leukaemia in Blacks from the West Indies.

Authors:  D Catovsky; M F Greaves; M Rose; D A Galton; A W Goolden; D R McCluskey; J M White; I Lampert; G Bourikas; R Ireland; A I Brownell; J M Bridges; W A Blattner; R C Gallo
Journal:  Lancet       Date:  1982-03-20       Impact factor: 79.321

8.  Multiple sclerosis and human T-cell lymphotropic retroviruses.

Authors:  H Koprowski; E C DeFreitas; M E Harper; M Sandberg-Wollheim; W A Sheremata; M Robert-Guroff; C W Saxinger; M B Feinberg; F Wong-Staal; R C Gallo
Journal:  Nature       Date:  1985 Nov 14-20       Impact factor: 49.962

9.  Functional properties of neoplastic T cells in adult T cell lymphoma/leukemia patients from the Caribbean.

Authors:  F Miedema; F G Terpstra; J W Smit; S Daenen; W Gerrits; U Hegde; E Matutes; D Catovsky; M F Greaves; C J Melief
Journal:  Blood       Date:  1984-02       Impact factor: 22.113

10.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

View more
  3 in total

1.  HTLV-II among Italian intravenous drug users and hemophiliacs.

Authors:  A R Zanetti; G Zehender; E Tanzi; C Galli; G Rezza; A Cargnel; A Boschini; D Mari; G Pizzocolo; F Mazzotta
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

2.  Antibodies to HTLV-1-2, HIV-1 and HIV-2 in syphilitic patients.

Authors:  N Manca; S Graifenberghi; D Colombrita
Journal:  Eur J Epidemiol       Date:  1990-06       Impact factor: 8.082

Review 3.  HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review.

Authors:  Daniel Bradshaw; Graham Philip Taylor
Journal:  Front Med (Lausanne)       Date:  2022-04-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.